Position in GILD
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$342,380
+$19,879 QoQ
Shares Held
2,710
+17.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,584
of 2,266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EASTERN BANK holds $295,354,591 across 16 Drug Manufacturers - General names. GILD ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,336 | $139,536,899 | |
| 2 | ABBV |
AbbVie Inc.
|
318,655 | $80,186,344 | |
| 3 | JNJ |
Johnson & Johnson
|
145,368 | $36,919,110 | |
| 4 | MRK |
Merck & Co., Inc.
|
191,760 | $24,641,159 | |
| 5 | NVO |
Novo Nordisk A S
|
122,583 | $5,876,628 | |
| 6 | PFE |
Pfizer Inc
|
88,290 | $2,126,023 | |
| 7 | AMGN |
Amgen Inc
|
4,449 | $1,611,071 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
27,740 | $1,598,378 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,380 | 2,710 | Shares | Defined | 2026-07-01 | |
| 2026-03-31 | $322,501 | 2,314 | Shares | Defined | 2026-04-07 | |
| 2025-12-31 | $276,287 | 2,251 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $91,575 | 825 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $91,467 | 825 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $120,453 | 1,075 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $99,297 | 1,075 | Shares | Defined | 2025-01-13 | |
| 2024-09-30 | $90,128 | 1,075 | Shares | Defined | 2024-10-21 | |
| No filing history on record for this holder in this stock. | ||||||